Medtronic stock trades at EUR 77.63, 8.7 percent higher year to date

Published on 10/08/2026 at 16:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic stock costs EUR 77.63 on October 8, 2026 after EUR 76.40. Fiscal first-quarter revenue rose 13.70 percent to USD 9.76 billion.

Isometrische 3D-Grafik der medizintechnischen Wertschöpfungskette von Rohstoff bis Klinik — Medtronic plc (ISIN IE00BTN1Y115) isometrische Grafik visualisiert Wertschöpfungskette von Rohstoff bis Krankenhaus schematisch, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) was trading at EUR 77.63 at Lang & Schwarz on October 8, 2026 at 3:43 p.m. CEST, up 1.61 percent versus the prior close of EUR 76.40. The stock was 8.70 percent higher year to date, placing the current euro quote in a broader market context.

Price stays above prior close

The Lang & Schwarz quote gained EUR 1.23 against the October 7, 2026 close. The bid was EUR 77.52 and the ask EUR 77.74 at the same timestamp, leaving a spread of EUR 0.22.

Primary-market data put Medtronic at USD 87.12 on the NYSE at 9:59 a.m. EDT on October 8, 2026. Trading volume stood at 2,227,651 shares against an average volume of 11,488,817 shares, or 19.39 percent of the average.

Range leaves room on both sides

The NYSE quote sat 18.80 percent above the USD 73.31 52-week low and 18.07 percent below the USD 106.33 52-week high. The range therefore places the US-dollar listing between its annual extremes rather than at either boundary.

Medtronic's year-to-date gain was 8.70 percent on October 7, 2026, compared with 13.97 percent for the S&P 500 over the same period, according to the performance figures displayed by Yahoo Finance. The comparison shows a 5.27 percentage-point gap between the stock and its benchmark.

Valuation and analyst target

The finance quote showed a market capitalization of USD 111.5 billion and a trailing P/E ratio of 21.45 on October 8, 2026. Its dividend yield was 3.00 percent, while the share count traded below the recent average-volume level.

As Markets Insider reported on October 5, 2026, Citi analyst Joanne Wuensch maintained a Buy rating and set a USD 110.00 price target. The target is stated in US dollars and is therefore separate from the euro reference quote.

Comparison with peers

Medtronic: plus 1.88 percent, P/E 21.45, market capitalization USD 111.5 billion
Abbott Laboratories: minus 0.28 percent, P/E 31.66, market capitalization USD 170.4 billion
Boston Scientific: plus 1.23 percent, P/E 17.12, market capitalization USD 62.6 billion

Next report date

Medtronic generated USD 9.76 billion in revenue and USD 1.14 diluted earnings per share in fiscal 2027's first quarter ended July 31, 2026. MarketBeat reported revenue of USD 9.76 billion for that quarter against USD 9.55 billion expected, a USD 0.21 billion comparison gap.

Yahoo Finance lists November 17, 2026 as Medtronic's estimated next earnings date. The date gives the market report a defined calendar point for the next company update.

Trading reference remains current

The Lang & Schwarz quote was EUR 77.63 on October 8, 2026 at 3:43 p.m. CEST, compared with the EUR 76.40 prior close from October 7, 2026. The euro quote and the NYSE figures use separate currencies and trading venues.

The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.